Lyra Therapeutics Inc (LYRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.1050 +0.0059 (+5.95%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.1080 +0.0030 (+2.86%) 19:59 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,435 | -62,680 | -55,278 | -43,513 | -22,127 |
| Depreciation Amortization | -1,805 | -3,218 | 575 | 1,001 | 95 |
| Accounts payable and accrued liabilities | -1,887 | 450 | -2,411 | 2,350 | 345 |
| Other Working Capital | -6,346 | -4,885 | 4,555 | 13,922 | -879 |
| Other Operating Activity | 33,462 | 7,029 | 9,174 | 420 | 1,423 |
| Operating Cash Flow | $-70,011 | $-63,304 | $-43,385 | $-25,820 | $-21,143 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 82,643 | -11,537 | N/A | N/A | N/A |
| PPE Investments | -2,338 | -1,047 | -164 | -3,385 | -1,775 |
| Purchase Of Investment | N/A | N/A | -64,842 | N/A | N/A |
| Investing Cash Flow | $80,305 | $-12,584 | $-65,006 | $-3,385 | $-1,775 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,821 | 69,345 | 100,503 | 604 | 59,900 |
| Other Financing Activity | -290 | -3,654 | -4,246 | -245 | 27,803 |
| Financing Cash Flow | $8,531 | $65,691 | $96,257 | $359 | $87,703 |
| Beginning Cash Position | 23,745 | 33,942 | 46,076 | 74,922 | 10,137 |
| End Cash Position | 42,570 | 23,745 | 33,942 | 46,076 | 74,922 |
| Net Cash Flow | $18,825 | $-10,197 | $-12,134 | $-28,846 | $64,785 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,011 | -63,304 | -43,385 | -25,820 | -21,143 |
| Capital Expenditure | -2,338 | -1,047 | -164 | -3,385 | -1,775 |
| Free Cash Flow | -72,349 | -64,351 | -43,549 | -29,205 | -22,918 |